Effects of neonatal repeated MK-801 treatment on delayed nonmatching-to-position responses in rats

NeuroReport

Volumn 19, Issue 9, 2008, Pages 969-973

  Kawabe, Kouichi ^a   Miyamoto, Eri ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Delayed nonmatching to position task; N methyl D aspartate receptors; Neonatal repeated treatment; Psychomimetic responses; Rats; Workingmemory

Indexed keywords

DIZOCILPINE; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE;

ADULTHOOD; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN WEIGHT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG EFFECT; FEMALE; HEAD MOVEMENT; LEARNING DISORDER; LONG TERM CARE; MALE; MEMORY DISORDER; MENTAL DISEASE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; SCHIZOPHRENIA; STEREOTYPY; TASK PERFORMANCE; WEIGHT REDUCTION; WORKING MEMORY; ANALYSIS OF VARIANCE; ANIMAL; BEHAVIOR; DOSE RESPONSE; DRUG ADMINISTRATION; MAZE TEST; REACTION TIME; SHORT TERM MEMORY; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; RATS; RATS, WISTAR; REACTION TIME; SPATIAL BEHAVIOR;

EID: 52249086965     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328302ee31     Document Type: Article

References (25)

1. Kawabe K, Ichitani Y, Iwasaki T. Effects of intrahippocampal AP5 treatment on radial-arm maze performance in rats. Brain Res 1998; 781:300-306.
2. Morris RGM, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986; 319:774-776.
3. Facchinetti F, Dall'Olio R, Ciani E, Sparapani M, Virgili M, Contestabile A. Long-lasting effects of chronic neonatal blockade of N-methyl-D-aspartate receptor through the competitive antagonist CGP 39551 in rats. Neuroscience 1994; 60:343-353.
4. Gorter JA, de Bruin JPC. Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat. Brain Res 1992; 580:12-17.
5. Gorter JA, Veerman M, Mirmiran M. Hippocampal neuronal responsiveness to NMDA agonists and antagonists in the adult rat neonatally treated with MK-801. Brain Res 1992; 572:176-181.
6. Gorter JA, Titulaer M, Bos NPA, Huisman E. Chronic neonatal MK-801 administration leads to a long-lasting increase in seizure sensitivity during the early stages of hippocampal kindling. Neurosci Lett 1991; 134:29-32.
7. Gorter JA, Veerman M, Mirmiran M, Bos NPA, Corner MA. Spectral analysis of the electroencephalogram in neonatal rats chronically treated with the NMDA antagonist MK-801. Dev Brain Res 1991; 64:37-41.
8. Kawabe K, Iwasaki T, Ichitani Y. Repeated treatment with N-methyl-D-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning. Brain Res 2007; 1169:77-86.
9. Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-D-aspartate receptor upregulation. Int J Dev Neurosci 2003; 21:159-167.
10. Stefani MR, Moghaddam B. Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 2005; 57:433-436.
11. Virgili M, Facchinetti F, Contestabile A. Chronic neonatal NMDA blockade results in long-term cholinergic increase in the rat spinal cord. Neuroreport 1994; 5:2023-2025.
12. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982; 297: 681-683.
13. Floresco SB, Seamans JK, Phillips AG. Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay. J Neurosci 1997; 17:1880-1890.
14. Olton DS, Papas BC. Spatial memory and hippocampal function. Neuropsychologia 1979; 17:669-682.
15. Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 1997; 54:159-165.
16. Goldman-Rakic PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 1994; 6:348-357.
17. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997; 121:65-94.
18. Bennetto L, Pennington BF, Rogers SJ. Intact and impaired memory functions in autism. Child Dev 1996; 67:1816-1835.
19. 3H]glutamate-binding sites in rat brain. J Neurosci 1985; 5:2909-2919.
20. Ishimaru MJ, Toru M. The glutamate hypothesis of schizophrenia: therapeutic implications. CNS Drugs 1997; 7:47-67.
21. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44:660-669.
22. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J, Dikranian K, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999; 283:70-74.
23. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 2002; 27:47-54.
24. Carlsson ML. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate-serotonin interactions for pharmacotherapy. J Neural Transm 1998; 105:525-535.
25. Volkmar FR, Nelson DS. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 1990; 29:127-129.